These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 3134847

  • 21. In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin.
    Toda M, Arao N, Nohara C, Susaki K, Tachibana A.
    Antimicrob Agents Chemother; 1985 Apr; 27(4):565-9. PubMed ID: 3890729
    [Abstract] [Full Text] [Related]

  • 22. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J, Cantón R, Liñares J, García de Lomas J, Gimeno C, Tubau F, Baquero F.
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
    [Abstract] [Full Text] [Related]

  • 23. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
    Ubukata K, Hikida M, Yoshida M, Nishiki K, Furukawa Y, Tashiro K, Konno M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
    [Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
    Hebeisen P, Heinze-Krauss I, Angehrn P, Hohl P, Page MG, Then RL.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
    [Abstract] [Full Text] [Related]

  • 26. In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics.
    Okamoto S, Hamana Y, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1111-6. PubMed ID: 3499115
    [Abstract] [Full Text] [Related]

  • 27. In vitro and in vivo activities of DQ-2556 and its mode of action.
    Tanaka M, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2595-601. PubMed ID: 1482128
    [Abstract] [Full Text] [Related]

  • 28. Antimicrobial activity of ceftriaxone: a review.
    Cleeland R, Squires E.
    Am J Med; 1984 Oct 19; 77(4C):3-11. PubMed ID: 6093515
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
    Fuchs PC, Jones RN, Barry AL, Thornsberry C.
    Antimicrob Agents Chemother; 1985 May 19; 27(5):679-82. PubMed ID: 3893316
    [Abstract] [Full Text] [Related]

  • 30. Role of the aminothiadiazolyl group in the antipseudomonal activity of cefclidin.
    Watanabe N, Sugiyama I.
    J Antibiot (Tokyo); 1992 Sep 19; 45(9):1526-32. PubMed ID: 1429239
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of cefodizime.
    Knothe H, Shah PM.
    Infection; 1992 Sep 19; 20 Suppl 1():S3-8. PubMed ID: 1526673
    [Abstract] [Full Text] [Related]

  • 32. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R, Altamura M, Arcamone F, Mazzariol A, Morandotti G, Sperning R, Cornaglia G.
    J Antimicrob Chemother; 1998 May 19; 41(5):513-25. PubMed ID: 9630405
    [Abstract] [Full Text] [Related]

  • 33. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
    Limbert M, Isert D, Klesel N, Markus A, Seeger K, Seibert G, Schrinner E.
    Antimicrob Agents Chemother; 1991 Jan 19; 35(1):14-9. PubMed ID: 2014969
    [Abstract] [Full Text] [Related]

  • 34. Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity.
    Limbert M, Klesel N, Seeger K, Seibert G, Winkler I, Schrinner E.
    J Antibiot (Tokyo); 1984 Aug 19; 37(8):892-900. PubMed ID: 6090373
    [Abstract] [Full Text] [Related]

  • 35. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus.
    Hayes MV, Orr DC.
    J Antimicrob Chemother; 1983 Aug 19; 12(2):119-26. PubMed ID: 6413485
    [Abstract] [Full Text] [Related]

  • 36. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y, Watanabe Y, Sakamoto H, Hatano K, Kuno K, Higashi Y, Kamimura T, Matsumoto Y, Tawara S, Matsumoto F.
    J Antibiot (Tokyo); 1993 Jan 19; 46(1):71-87. PubMed ID: 8436562
    [Abstract] [Full Text] [Related]

  • 37. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.
    Fujimura T, Yamano Y, Yoshida I, Shimada J, Kuwahara S.
    Antimicrob Agents Chemother; 2003 Mar 19; 47(3):923-31. PubMed ID: 12604523
    [Abstract] [Full Text] [Related]

  • 38. Susceptibility to beta-lactam antibiotics of Pseudomonas aeruginosa overproducing penicillin-binding protein 3.
    Liao X, Hancock RE.
    Antimicrob Agents Chemother; 1997 May 19; 41(5):1158-61. PubMed ID: 9145889
    [Abstract] [Full Text] [Related]

  • 39. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T, Tateda E, Hiramatsu K, Yokota T.
    Jpn J Antibiot; 1996 Apr 19; 49(4):324-37. PubMed ID: 8786624
    [Abstract] [Full Text] [Related]

  • 40. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
    Markus A, Klesel N, Wollmann T, Isert D, Limbert M, Schrinner E, Seibert G, Bauernfeind A, Jungwirth R, Wilhelm R.
    J Antibiot (Tokyo); 1992 Apr 19; 45(4):521-6. PubMed ID: 1592684
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.